Advertisement

Topics

Bristol-Myers Squibb to acquire IFM Therapeutics to expand cancer pipeline

02:09 EDT 4 Aug 2017 | Pharmaceutical Business Review

Bristol-Myers Squibb has agreed to acquire Boston-based IFM Therapeutics for an upfront payment of $300m to strengthen its oncology pipeline.

Original Article: Bristol-Myers Squibb to acquire IFM Therapeutics to expand cancer pipeline

NEXT ARTICLE

More From BioPortfolio on "Bristol-Myers Squibb to acquire IFM Therapeutics to expand cancer pipeline"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...